IPCALABNSEIPCA Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Mon, 16 Mar · 11:19 IST

IPCA Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

IPCALAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.5%1-day move
₹1570.00
prior close
₹1553.10
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.3-0.4-0.4-1.5-1.2-1.9-2.7-3.2+0.1-7.6-6.5+5.1-1.2
Up moveDown movePending
AI summary

Ipca Laboratories has informed the exchanges that the trading window for insiders will be closed from 1st April 2026 until 48 hours after the company declares its audited financial results for the fourth quarter and financial year ending 31st March 2026. This is a standard compliance requirement under SEBI's Prohibition of Insider Trading Regulations, 2015. The date of the board meeting to consider and approve the audited financial results will be communicated to the stock exchanges later. The letter is signed by Harish Kamath, Corporate Counsel and Company Secretary.

Likely market impact

This is a routine regulatory filing and does not have a direct impact on shareholders or the stock price. However, it signals that the company's Q4 and FY26 earnings announcement is approaching, and insiders will be restricted from trading during this period.